With more than half of Icon’s centres participating in clinical trials and with over 60 GCP trained investigators, Icon offers Australia’s largest private cancer clinical trials program. Icon is committed to delivering clinical trials and research programs to our patients and Icon’s standard of care is to offer patients an opportunity to participate in a clinical trial or research study if Icon has an open and recruiting trial and the patient is eligible. Icon has approximately 70 clinical trials open for recruitment, over 50 active studies closed for recruitment with patients in treatment and follow-up, and over 350 patients currently on active trials across haematology, medical oncology and radiation oncology. This includes clinical trials sponsored by the pharmaceutical industry, along with collaborative studies undertaken in partnership with various universities and collaborative groups.
It is important to us that you and your loved ones are kept well informed and supported throughout the trial process. We employ a team of nurses, clinical trial coordinators and data managers to coordinate and manage the needs of each patient across the entire period of the trial. By providing access to a wide-range of clinical trials across a multitude of cancer types, Icon helps to contribute to breakthroughs and advancements in cancer treatments for the benefit of current and future patients.
Download our 2020 Research brochure here.